Publicaciones (21) Publicaciones en las que ha participado algún/a investigador/a

2009

  1. Adolescencia, consumo de drogas y comportamientos de riesgo

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 11, Núm. 1, pp. 8-9

  2. Allosteric modulation of 5-HT1A receptors by zinc: Binding studies

    Neuropharmacology, Vol. 56, Núm. 2, pp. 455-462

  3. B cell receptor-induced growth arrest and apoptosis in WEHI-231 immature B lymphoma cells involve cyclic AMP and Epac proteins

    Cellular Signalling, Vol. 21, Núm. 4, pp. 609-621

  4. Bases neurobiológicas de la depression

    Salud(i)Ciencia, Vol. 16, Núm. 8, pp. 835-838

  5. Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum

    Journal of Biological Chemistry, Vol. 284, Núm. 31, pp. 20668-20675

  6. Descifrando la anatomía molecular de un tejido mediante análisis lipidómico por espectrometría de masas

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 106, Núm. 3, pp. 77-84

  7. Effect of the CB 1 receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices

    British Journal of Pharmacology, Vol. 158, Núm. 6, pp. 1579-1587

  8. Functional autoradiography and gene expression analysis applied to the characterization of the α2-adrenergic system in the chicken brain

    Journal of Chemical Neuroanatomy, Vol. 38, Núm. 4, pp. 282-291

  9. Gizonezkoentzako pilula antikontzeptiboa: errealitatea ala fikzioa?

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 22, pp. 121-129

  10. Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents

    British Journal of Pharmacology, Vol. 156, Núm. 4, pp. 649-661

  11. Guanidine and 2-Aminoimidazoline Aromatic Derivatives as a2-Adrenoceptor Ligands: Searching for Structure-Activity Relationships

    Journal of Medicinal Chemistry, Vol. 52, Núm. 3, pp. 601-609

  12. Immunodensity and mRNA expression of A2A adenosine, D 2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: Effect of antipsychotic treatment

    Psychopharmacology, Vol. 206, Núm. 2, pp. 313-324

  13. Implicación del sistema cannabinoide endógeno en el alcoholismo

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 11, Núm. 2, pp. 85-95

  14. Inhibitory transmission in locus coeruleus neurons expressing GABA a receptor epsilon subunit has a number of unique properties

    Journal of Neurophysiology, Vol. 102, Núm. 4, pp. 2312-2325

  15. Levodopa-induced dyskinesias in parkinson disease are independent of the extent of striatal dopaminergic denervation: A pharmacological and SPECT study

    Clinical Neuropharmacology, Vol. 32, Núm. 6, pp. 326-329

  16. Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H 1) Effect of Bilastine

    Clinical Pharmacokinetics, Vol. 48, Núm. 8, pp. 543-554

  17. Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: Relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity

    Neuroscience, Vol. 161, Núm. 1, pp. 23-38

  18. Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients

    European Journal of Clinical Pharmacology, Vol. 65, Núm. 11, pp. 1121-1130

  19. Prevalence of CYP2C9 polymorphisms in the south of Europe

    Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 306-310

  20. ¿Es realmente el consumo de cannabis un factor de riesgo para la esquizofrenia?

    Norte de Salud Mental, Vol. 8, Núm. 34, pp. 23-33